Skip to main content
TipRanks
Go Ultimate75% OFF

Pharming Group (PHG) Income Statement

0 Followers

Pharming Group Income Statement

Last quarter (Q3 2026), Pharming Group's total revenue was €117.56M, an increase of 20.84% from the same quarter last year. In Q3, Pharming Group's net income was €22.43M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
€ 376.13M€ 297.20M€ 245.32M€ 205.62M€ 198.87M
€ 330.63M€ 261.80M€ 220.10M€ 188.06M€ 177.73M
€ 309.75M€ 265.47M€ 242.39M€ 178.20M€ 158.72M
Depreciation and Amortization€ 11.22M€ 16.07M€ 15.93M€ 13.19M€ 19.61M
€ 34.78M€ 16.32M€ 9.88M€ 33.53M€ 48.78M
€ 20.88M€ -3.67M€ -22.29M€ 9.86M€ 19.01M
€ -8.03M€ -4.83M€ 10.28M€ 5.13M€ 4.07M
€ 12.85M€ -8.49M€ -12.01M€ 14.99M€ 23.08M
€ 2.85M€ -11.84M€ -10.55M€ 13.67M€ 16.00M
Per Share Metrics
Basic EPS€ 0.04€ -0.18€ -0.14€ 0.17€ 0.23
Diluted EPS€ 0.04€ -0.18€ -0.14€ 0.16€ 0.21
Weighted Average Shares Outstanding71.32M68.92M65.70M82.54M87.64M
Weighted Average Shares Outstanding (Diluted)71.32M68.92M65.70M84.28M87.64M

Currency in EUR

Pharming Group Earnings and Revenue History

-200M0200M400M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin